UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys Shares of 20,200 iShares Biotechnology ETF (NASDAQ:IBB)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, HoldingsChannel.com reports. The fund bought 20,200 shares of the financial services provider’s stock, valued at approximately $2,941,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in IBB. Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $29,000. Highline Wealth Partners LLC acquired a new position in iShares Biotechnology ETF during the 3rd quarter valued at $30,000. Ashton Thomas Securities LLC bought a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $36,000. Voisard Asset Management Group Inc. acquired a new stake in iShares Biotechnology ETF in the 3rd quarter worth $59,000. Finally, Aptus Capital Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 36.5% during the 3rd quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after purchasing an additional 114 shares during the period. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 0.8 %

NASDAQ IBB opened at $136.61 on Friday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The firm has a 50-day simple moving average of $141.84 and a 200 day simple moving average of $142.25.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.